Patent details
EP2782602 Title: Nucleotide DIMS0-150 for use in the treatment of chronic active ulcerative colitis
Basic Information
- Publication number:
- EP2782602
- PCT Application Number:
- EP2012073501
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP127909042
- PCT Publication Number:
- WO2013076262
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Nucleotide DIMS0-150 for use in the treatment of chronic active ulcerative colitis
- French Title of Invention:
- Nucleotide DIMS0-150 por son utilisation dans le traitement de la colite ulcéreuse active chronique
- German Title of Invention:
- Nukleotid DIMS0-150 zur Verwendung bei der Behandlung von chronisch aktiver Colitis ulcerosa
- SPC Number:
Dates
- Filing date:
- 23/11/2012
- Grant date:
- 26/06/2019
- EP Publication Date:
- 01/10/2014
- PCT Publication Date:
- 30/05/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/06/2019
- EP B1 Publication Date:
- 26/06/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 23/11/2024
- Expiration date:
- 23/11/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/06/2019
- Name:
- Index Pharmaceuticals AB
- Address:
- Tomtebodavägen 23a, 171 77 Stockholm, Sweden (SE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 11/09/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ADMYRE, Charlotte
- Address:
- Sweden (SE)
2
- Name:
- VON STEIN, Petra
- Address:
- Sweden (SE)
3
- Name:
- ZARGARI, Arezou
- Address:
- Sweden (SE)
4
- Name:
- VON STEIN, Oliver
- Address:
- Sweden (SE)
Priority
1
- Priority Number:
- 11190826
- Priority Date:
- 25/11/2011
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 201261595230 P
- Priority Date:
- 06/02/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 48/00; A61P 37/00;
Publication
European Patent Bulletin
- Issue number:
- 201926
- Publication date:
- 26/06/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 16/10/2023
- Last Annual Fee Paid Number:
- 12
- Last Annual Fee Paid Amount:
- 165 Euro
- Payer:
- OFFICE FREYLINGER S.A.
| Filing date | Document type | Number of pages |
|---|---|---|
| 11/09/2019 | Power Of Attorney | 1 |
| 24/09/2019 | Outgoing Correspondence | 1 |